A £4.5m investment from Solent LEP has helped a world-leading Centre for Cancer Immunology hit its £25m funding target.
The development of the UK’s first dedicated Centre for Cancer Immunology will support innovation in the field of immunology research, and place the Solent firmly on the map as a global Centre of Excellence for the development and delivery of new therapies that will cure cancer.
The investment will also create a significant number of new jobs in the area and place the Solent in the driving seat as the location for next generation of cancer therapies, accelerating the growth of the Life Sciences Sector and new business growth clustering around the facility to leverage off its global expertise.
To celebrate achieving its goal, the University of Southampton is encouraging people to help spread the news in the run up to World Cancer Day on 4 Feb 2018. It is asking them to wear something white and share photos on social media using the hashtag #WearingWhite.
More details on the fundraising announcement are available here
Sir Christopher Snowden, vice-Chancellor at the University of Southampton, said:
Despite an extremely successful campaign raising more than £13.5m to bring forward this project, we were still left with a funding gap of £9.5m. The LEPs investment of £4.5m from its skills and innovation fund has de-risked the project sufficiently to allow the University to underwrite the remaining funding gap while it completes its fund raising campaign and, together, secured the commencement of construction in 2015. Without Solent LEP support, Southampton’s lead in this ground-breaking research would be jeopardised by the delay.
CIC Youtube Video: https://www.youtube.com/watch?v=FDk0NWNbrc8
We have moved - visit our new website www.solentpartners.com